Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc (NQ: APTX )

2.460 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 207,008
Open 2.340
Bid (Size) 2.370 (2)
Ask (Size) 2.510 (2)
Prev. Close 2.460
Today's Range 2.300 - 2.510
52wk Range 2.300 - 6.470
Shares Outstanding 66,889,625
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the election of Joan... 
From Business Wire News Releases
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company... 
From Business Wire News Releases

Performance

YTD
-28.49%
-28.49%
1 Month
-13.99%
-13.99%
3 Month
-39.41%
-39.41%
6 Month
-23.60%
-23.60%
1 Year
-36.92%
-36.92%

More News

Read More
Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
From Business Wire News Releases
Aptinyx to Participate in Upcoming Conferences
From Business Wire News Releases
3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Stocks That Hit 52-Week Lows On Wednesday
Tags Markets AVIR HRTG
From Benzinga
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tags Top Gainers Pre/Market Outlook ILMN
From Benzinga
Aptinyx Stock Is Trading Higher After Restarting NYX-458 Study In Dementia Associated Cognitive Impairment
Tags Biotech Market News APTX
From Benzinga
Aptinyx Inc. (APTX) Q4 2020 Earnings Call Transcript
Tags APTX Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.